WILLIAMS AND JENSEN, PLLC

Lobbying for SANOFI, U.S. · Global life sciences company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Apr 21, 2025

Lobbying activity 5

Health Issues

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. American Relief Act (P.L. 118-158).

Medicare/Medicaid

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. American Relief Act (P.L. 118-158).

Medical/Disease Research/Clinical Labs

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs.

Taxation/Internal Revenue Code

Monitor general tax issues related to international tax, vaccine excise taxes and orphan drug tax issues.

Budget/Appropriations

Policies impacting vaccine access, disease prevention programs, and prescription drug labeling requirements.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.